Babak Tofighi1, Helen-Maria Lekas2, Sharifa Z Williams3, Daniele Martino3, Chloe Blau3, Crystal F Lewis2. 1. Nathan S. Kline Institute for Psychiatric Research, Division of Social Solutions and Services Research, Center for Research on Cultural & Structural Equity in Behavioral Health, United States of America; New York University School of Medicine, Department of Population Health, United States of America; Center for Drug Use and HIV Research, NYU College of Global Public Health, United States of America. Electronic address: babak.tofighi@nki.rfmh.org. 2. Nathan S. Kline Institute for Psychiatric Research, Division of Social Solutions and Services Research, Center for Research on Cultural & Structural Equity in Behavioral Health, United States of America; New York University School of Medicine, Department of Psychiatry, United States of America. 3. Nathan S. Kline Institute for Psychiatric Research, Division of Social Solutions and Services Research, Center for Research on Cultural & Structural Equity in Behavioral Health, United States of America.
Abstract
INTRODUCTION: The purpose of this study is to assess community pharmacists' attitudes and experiences related to naloxone dispensation and counseling in non-urban areas in New York State to better understand individual and structural factors that influence pharmacy provision of naloxone. MATERIALS AND METHODS: The study conducted interviewer-administered semistructured surveys among community pharmacists in retail, independent, and supermarket pharmacies between October 2019 and December 2019. The 29-item survey ascertained pharmacists' demographic and practice characteristics; experiences and beliefs related to naloxone dispensation; and attitudes toward expansion of pharmacy services to include on-site public health services for persons who use opioids. The study used Chi square tests to determine associations between each characteristic and self-reported naloxone dispensation (any vs. none). RESULTS: A total of 60 of the 80 community pharmacists that the study team had approached agreed to participate. A majority were supportive of expanding pharmacy-based access to vaccinations (93.3%), on-site HIV testing, or referrals (75% and 96.7%, respectively), providing information on safe syringe use (93.3%) and disposal (98.3%), and referrals to medical/social services (88.3%), specifically substance use treatment (90%). A majority of pharmacist respondents denied negative impacts on business with over half reporting active naloxone dispensation (58.3%). Pharmacists dispensing naloxone were more likely to be multilingual (p < 0.03), and to specifically support on-site HIV testing (p < 0.02) than those who were not dispensing naloxone. DISCUSSION: Community pharmacists were highly favorable of naloxone dispensation in rural and small metro area pharmacies in NY, and those fluent in additional language(s) and supportive of on-site HIV testing were associated with active naloxone dispensation. While active naloxone dispensation was low, pharmacists appear supportive of a "frontline public health provider" model, which could facilitate naloxone uptake and warrants large-scale investigation. CONCLUSION: Rural and small metro area pharmacists are generally favorable of naloxone dispensation.
INTRODUCTION: The purpose of this study is to assess community pharmacists' attitudes and experiences related to naloxone dispensation and counseling in non-urban areas in New York State to better understand individual and structural factors that influence pharmacy provision of naloxone. MATERIALS AND METHODS: The study conducted interviewer-administered semistructured surveys among community pharmacists in retail, independent, and supermarket pharmacies between October 2019 and December 2019. The 29-item survey ascertained pharmacists' demographic and practice characteristics; experiences and beliefs related to naloxone dispensation; and attitudes toward expansion of pharmacy services to include on-site public health services for persons who use opioids. The study used Chi square tests to determine associations between each characteristic and self-reported naloxone dispensation (any vs. none). RESULTS: A total of 60 of the 80 community pharmacists that the study team had approached agreed to participate. A majority were supportive of expanding pharmacy-based access to vaccinations (93.3%), on-site HIV testing, or referrals (75% and 96.7%, respectively), providing information on safe syringe use (93.3%) and disposal (98.3%), and referrals to medical/social services (88.3%), specifically substance use treatment (90%). A majority of pharmacist respondents denied negative impacts on business with over half reporting active naloxone dispensation (58.3%). Pharmacists dispensing naloxone were more likely to be multilingual (p < 0.03), and to specifically support on-site HIV testing (p < 0.02) than those who were not dispensing naloxone. DISCUSSION: Community pharmacists were highly favorable of naloxone dispensation in rural and small metro area pharmacies in NY, and those fluent in additional language(s) and supportive of on-site HIV testing were associated with active naloxone dispensation. While active naloxone dispensation was low, pharmacists appear supportive of a "frontline public health provider" model, which could facilitate naloxone uptake and warrants large-scale investigation. CONCLUSION: Rural and small metro area pharmacists are generally favorable of naloxone dispensation.
Authors: Mark Faul; Michael W Dailey; David E Sugerman; Scott M Sasser; Benjamin Levy; Len J Paulozzi Journal: Am J Public Health Date: 2015-04-23 Impact factor: 9.308
Authors: Jennifer L Nguyen; Lauren R Gilbert; Lauren Beasley; John J Brooks; Jennifer Elliott; K Bryant Smalley; Jacob C Warren Journal: JAMA Netw Open Date: 2020-02-05
Authors: Shane R Mueller; Alexander Y Walley; Susan L Calcaterra; Jason M Glanz; Ingrid A Binswanger Journal: Subst Abus Date: 2015-03-16 Impact factor: 3.716
Authors: Rebecca B Naumann; Christine Piette Durrance; Shabbar I Ranapurwala; Anna E Austin; Scott Proescholdbell; Robert Childs; Stephen W Marshall; Susan Kansagra; Meghan E Shanahan Journal: Drug Alcohol Depend Date: 2019-08-30 Impact factor: 4.492
Authors: Susannah Slocum; Jenny E Ozga; Rebecca Joyce; Alexander Y Walley; Robin A Pollini Journal: BMC Public Health Date: 2022-04-13 Impact factor: 3.295